University Schleswig Holstein, Campus Kiel, Dept Orthopedic Surgery and Traumatology, Kiel, Germany.
Pain Physician. 2013 May-Jun;16(3):185-96.
BACKGROUND: Chronic radicular pain can occur after disc pathology and failed back surgery. An evidence-based effective therapeutic option is not available nor does a gold standard exist. OBJECTIVES: A randomized controlled trial to analyze the clinical efficacy of percutaneous epidural lysis of adhesions in chronic radicular pain. STUDY DESIGN: Prospective randomized placebo controlled interventional trial. Power calculation based on a feasibility trial. SETTING: Medical university centers. METHODS: Within 4 years a total of 381 patients with chronic radicular pain lasting longer than 4 months which failed to respond to conservative treatments were screened and 90 patients were enrolled. They were randomly assigned to receive either percutaneous neurolysis or placebo with concealed allocation in permuted blocks of 4 to 8, stratified by treatment center. The primary outcome measure was the differences in percent change of Oswestry Disability Index (ODI) scores 3 months after intervention. Secondary outcome measures were difference in percent change of ODI scores and Visual Analog Scale (VAS) 6 and 12 months after intervention and success rates defined as at least 50% reduction in ODI scores and VAS scores (mean change from baseline) at 3, 6, and 12 months after treatment. Explorative, 2-sided group comparisons for baseline characteristics between active treatment and controls were done using the t-test for 2 independent samples for quantitative data and Fisher's exact test for binary data. RESULTS: The ODI and VAS scores as well as the success rates for ODI vs VAS were significantly better 3, 6, and 12 months in the lysis group vs the control group. The ODI in the lysis group improved from 55.3 ± 11.6 to 26.4 ± 10.8 after 3 months. The placebo group improved from 55.4 ± 11.5 to 41.8 ± 14.6 (P < 0.01). VAS improved from 6.7 ± 1.1 to 2.9 ± 1.9 in the active group and from 6.7 ± 1.1 to 4.8 ± 2.2 (P < 0.01) after placebo. Twelve month follow-up shows further improvement, the differences remain significant. In multiple linear regression, forward and backward variable selection methods resulted in the same covariate model confirming the univariate result for group comparison in the primary analysis. No severe side effects occurred but minor transient neurological effects such as partial sensomotoric deficits did. One dura puncture and one catheter displacement were found. LIMITATIONS: Specific effects of single treatment components cannot be specified because there was no imaging examination after treatment. CONCLUSION: Based on the findings of our study as well as other studies, we believe the minimally invasive percutaneous adhesiolysis procedure should be the first choice treatment option for patients with chronic lumbosacral radicular pain who present with clinical history and findings similar to those of the patients enrolled in our study.
背景:椎间盘病变和腰椎术后失败综合征可引起慢性根性疼痛。目前尚无有效的循证治疗选择,也没有金标准。
目的:分析经皮硬膜外粘连松解术治疗慢性根性疼痛的临床疗效。
研究设计:前瞻性随机安慰剂对照干预试验。基于可行性试验进行了功效计算。
设置:医科大学中心。
方法:在 4 年内,对 381 例慢性根性疼痛持续时间超过 4 个月且对保守治疗无反应的患者进行了筛选,其中 90 例患者入组。他们被随机分配接受经皮神经松解术或安慰剂治疗,分配采用 4 至 8 个随机排列的隐藏块,按治疗中心分层。主要观察指标为干预后 3 个月时 Oswestry 功能障碍指数(ODI)评分变化的百分比差异。次要观察指标为 ODI 评分和视觉模拟量表(VAS)评分的百分比变化以及定义为 ODI 评分和 VAS 评分(治疗前基线)至少降低 50%的治疗后 3、6 和 12 个月的成功率。采用双侧 t 检验对活性治疗组和对照组之间的基线特征进行探索性、2 组比较,对定量数据采用 2 个独立样本 t 检验,对二项数据采用 Fisher 精确检验。
结果:ODI 和 VAS 评分以及 ODI 与 VAS 的成功率在松解组 3、6 和 12 个月时均明显优于对照组。松解组 ODI 从 55.3 ± 11.6 改善至 3 个月时的 26.4 ± 10.8。安慰剂组从 55.4 ± 11.5 改善至 41.8 ± 14.6(P < 0.01)。VAS 在松解组从 6.7 ± 1.1 改善至 2.9 ± 1.9,在安慰剂组从 6.7 ± 1.1 改善至 4.8 ± 2.2(P < 0.01)。12 个月随访显示进一步改善,差异仍有统计学意义。多元线性回归中,向前和向后变量选择方法得出相同的协变量模型,证实了主要分析中组间比较的单变量结果。没有发生严重的副作用,但有轻微的短暂神经效应,如部分感觉运动缺陷。发现 1 例硬脊膜穿刺和 1 例导管移位。
局限性:由于治疗后未进行影像学检查,因此无法确定单一治疗成分的具体效果。
结论:基于我们研究的发现以及其他研究,我们认为对于临床病史和发现与我们研究入组患者相似的慢性腰骶神经根痛患者,微创经皮粘连松解术应作为首选治疗选择。
Cureus. 2023-10-29
Healthcare (Basel). 2023-8-21